FLYW Investors Have Opportunity to Lead Flywire Corporation Securities Fraud Lawsuit

NEW YORK, Aug. 9, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Flywire Corporation (NASDAQ: FLYW) between February 28, 2024 and February 25, 2025, both dates inclusive (the “Class Period”), of the important September 23, 2025 lead plaintiff deadline. So what: If you purchased Flywire securities during the […]

Thumzup Media Corporation Announces Update to the Terms of its Proposed Public Offering

LOS ANGELES, Aug. 9, 2025 /PRNewswire/ — Thumzup Media Corporation (Nasdaq: TZUP) (“Thumzup” or the “Company”), a digital asset accumulator and advertising industry disruptor, today announced that it has updated the terms of its previously disclosed best efforts public offering to now consist of common stock and, in lieu of common stock to certain investors, pre-funded […]

LMT Investors Have Opportunity to Lead Lockheed Martin Corporation Securities Fraud Lawsuit

NEW YORK, Aug. 9, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lockheed Martin Corporation (NYSE: LMT) between January 23, 2024 and July 21, 2025, both dates inclusive (the “Class Period”), of the important September 26, 2025 lead plaintiff deadline. So what: If you purchased Lockheed […]

LAZR Investors Have Opportunity to Lead Luminar Technologies, Inc. Securities Fraud Lawsuit

NEW YORK, Aug. 9, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Luminar Technologies, Inc. (NASDAQ: LAZR) between March 20, 2025 and May 14, 2025, both dates inclusive (the “Class Period”), of the important September 22, 2025 lead plaintiff deadline. So what: If you purchased Luminar […]

RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit

NEW YORK, Aug. 9, 2025 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of RxSight, Inc. (NASDAQ: RXST) between November 7, 2024 and July 8, 2025, both dates inclusive (the “Class Period”), of the important September 22, 2025 lead plaintiff deadline. So What: If you purchased RxSight securities […]